| Dr Charles R Whiteman, MD | |
|
1 Medical Center Dr, Morgantown, WV 26506-1200 | |
| (304) 598-4000 | |
| Not Available |
| Full Name | Dr Charles R Whiteman |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Experience | 39 Years |
| Location | 1 Medical Center Dr, Morgantown, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629152202 | NPI | - | NPPES |
| 0042016000 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 15634 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| West Virginia University Hospitals | Morgantown, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| West Virginia University Medical Corporation | 1052224565 | 1613 |
News Archive
Stem Cell Innovations announced today that the Company has signed a Master Services Agreement to provide research and assay services in support of Agennix's talactoferrin program. The assay utilizes SCLL's C3A human liver cell line.
A multicenter team of researchers reports that a full genomic analysis of tumor samples from a small number of people who died of pancreatic cancer suggests that chemical changes to DNA that do not affect the DNA sequence itself yet control how it operates confer survival advantages on subsets of pancreatic cancer cells.
The long and challenging effort to find blood-borne markers for cancer and other diseases may soon enter a new realm of success using a new nanoparticle that preferentially and rapidly removes small proteins and other molecules from blood while simultaneously protecting them from degradation.
Caspase-12 is a molecule with a death-wish. Found only in people of African descent, this protein shuts down our body's immune system, opening the door to potentially lethal infections. In a groundbreaking new study published in the prestigious journal Nature this week, the team that first discovered the role of caspase-12 in humans has now uncovered the mechanism by which it sabotages us, allowing researchers to develop methods to counter its damaging effects.
Developing countries Monday at a meeting in Istanbul said they should get larger percentages of the vote at the World Bank and the International Monetary Fund (IMF), the Associated Press reports.
› Verified 3 days ago
| Entity Name | West Virginia University Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275504508 PECOS PAC ID: 1052224565 Enrollment ID: O20031111000207 |
News Archive
Stem Cell Innovations announced today that the Company has signed a Master Services Agreement to provide research and assay services in support of Agennix's talactoferrin program. The assay utilizes SCLL's C3A human liver cell line.
A multicenter team of researchers reports that a full genomic analysis of tumor samples from a small number of people who died of pancreatic cancer suggests that chemical changes to DNA that do not affect the DNA sequence itself yet control how it operates confer survival advantages on subsets of pancreatic cancer cells.
The long and challenging effort to find blood-borne markers for cancer and other diseases may soon enter a new realm of success using a new nanoparticle that preferentially and rapidly removes small proteins and other molecules from blood while simultaneously protecting them from degradation.
Caspase-12 is a molecule with a death-wish. Found only in people of African descent, this protein shuts down our body's immune system, opening the door to potentially lethal infections. In a groundbreaking new study published in the prestigious journal Nature this week, the team that first discovered the role of caspase-12 in humans has now uncovered the mechanism by which it sabotages us, allowing researchers to develop methods to counter its damaging effects.
Developing countries Monday at a meeting in Istanbul said they should get larger percentages of the vote at the World Bank and the International Monetary Fund (IMF), the Associated Press reports.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles R Whiteman, MD Po Box 897, Morgantown, WV 26507-0897 Ph: (304) 293-7401 | Dr Charles R Whiteman, MD 1 Medical Center Dr, Morgantown, WV 26506-1200 Ph: (304) 598-4000 |
News Archive
Stem Cell Innovations announced today that the Company has signed a Master Services Agreement to provide research and assay services in support of Agennix's talactoferrin program. The assay utilizes SCLL's C3A human liver cell line.
A multicenter team of researchers reports that a full genomic analysis of tumor samples from a small number of people who died of pancreatic cancer suggests that chemical changes to DNA that do not affect the DNA sequence itself yet control how it operates confer survival advantages on subsets of pancreatic cancer cells.
The long and challenging effort to find blood-borne markers for cancer and other diseases may soon enter a new realm of success using a new nanoparticle that preferentially and rapidly removes small proteins and other molecules from blood while simultaneously protecting them from degradation.
Caspase-12 is a molecule with a death-wish. Found only in people of African descent, this protein shuts down our body's immune system, opening the door to potentially lethal infections. In a groundbreaking new study published in the prestigious journal Nature this week, the team that first discovered the role of caspase-12 in humans has now uncovered the mechanism by which it sabotages us, allowing researchers to develop methods to counter its damaging effects.
Developing countries Monday at a meeting in Istanbul said they should get larger percentages of the vote at the World Bank and the International Monetary Fund (IMF), the Associated Press reports.
› Verified 3 days ago
Dr. Nicole Lee Dorinzi, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Drive, Po 9149, Morgantown, WV 26506 Phone: 304-216-0980 | |
Kevin J Blankenship, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 63 Wharf St, Suite 100, Morgantown, WV 26501 Phone: 304-291-3627 Fax: 304-598-3630 | |
Dr. Joseph Michael Hartzog, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 710 Venture Dr, Morgantown, WV 26508 Phone: 304-291-5533 Fax: 304-291-5548 | |
Dr. Christopher Edwards, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 J D Anderson Dr, Morgantown, WV 26505 Phone: 304-598-1200 | |
Dr. John Harold Marsh, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 J D Anderson Dr, Emergency Department, Morgantown, WV 26505 Phone: 304-598-1200 | |
Matthew Kersteter, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Drive, Po 9149, Morgantown, WV 26506 Phone: 304-293-7215 Fax: 304-293-6702 | |
Dr. Jack F Ditty Iii, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 Stadium Drive, Morgantown, WV 26505 Phone: 304-598-4000 Fax: 304-293-6963 |